Pfizer Inc.

PFE.F plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PFE.F stands at 121B. In comparison, LLY.DE has a market cap of 633.2B. Regarding current trading prices, PFE.F is priced at €20.72, while LLY.DE trades at €661.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PFE.F currently has a P/E ratio of 17.60, whereas LLY.DE's P/E ratio is 63.45. In terms of profitability, PFE.F's ROE is +0.09%, compared to LLY.DE's ROE of +0.77%. Regarding short-term risk, PFE.F is less volatile compared to LLY.DE. This indicates potentially lower risk in terms of short-term price fluctuations for PFE.F.

PFE.F plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PFE.F stands at 121B. In comparison, JNJ.DE has a market cap of 320.8B. Regarding current trading prices, PFE.F is priced at €20.72, while JNJ.DE trades at €129.26.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PFE.F currently has a P/E ratio of 17.60, whereas JNJ.DE's P/E ratio is 17.34. In terms of profitability, PFE.F's ROE is +0.09%, compared to JNJ.DE's ROE of +0.30%. Regarding short-term risk, PFE.F is less volatile compared to JNJ.DE. This indicates potentially lower risk in terms of short-term price fluctuations for PFE.F.

PFE.F plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PFE.F stands at 121B. In comparison, 4AB.DE has a market cap of 286.2B. Regarding current trading prices, PFE.F is priced at €20.72, while 4AB.DE trades at €157.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PFE.F currently has a P/E ratio of 17.60, whereas 4AB.DE's P/E ratio is 79.80. In terms of profitability, PFE.F's ROE is +0.09%, compared to 4AB.DE's ROE of +0.96%. Regarding short-term risk, PFE.F is less volatile compared to 4AB.DE. This indicates potentially lower risk in terms of short-term price fluctuations for PFE.F.

PFE.F plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PFE.F stands at 121B. In comparison, ZEG.DE has a market cap of 188.4B. Regarding current trading prices, PFE.F is priced at €20.72, while ZEG.DE trades at €118.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PFE.F currently has a P/E ratio of 17.60, whereas ZEG.DE's P/E ratio is 28.19. In terms of profitability, PFE.F's ROE is +0.09%, compared to ZEG.DE's ROE of +0.19%. Regarding short-term risk, PFE.F is less volatile compared to ZEG.DE. This indicates potentially lower risk in terms of short-term price fluctuations for PFE.F.

PFE.F plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PFE.F stands at 121B. In comparison, 6MK.DE has a market cap of 175.5B. Regarding current trading prices, PFE.F is priced at €20.72, while 6MK.DE trades at €67.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PFE.F currently has a P/E ratio of 17.60, whereas 6MK.DE's P/E ratio is 11.65. In terms of profitability, PFE.F's ROE is +0.09%, compared to 6MK.DE's ROE of +0.38%. Regarding short-term risk, PFE.F is less volatile compared to 6MK.DE. This indicates potentially lower risk in terms of short-term price fluctuations for PFE.F.

PFE.F plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PFE.F stands at 121B. In comparison, AMG.DE has a market cap of 127.7B. Regarding current trading prices, PFE.F is priced at €20.72, while AMG.DE trades at €237.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PFE.F currently has a P/E ratio of 17.60, whereas AMG.DE's P/E ratio is 24.90. In terms of profitability, PFE.F's ROE is +0.09%, compared to AMG.DE's ROE of +0.66%. Regarding short-term risk, PFE.F is less volatile compared to AMG.DE. This indicates potentially lower risk in terms of short-term price fluctuations for PFE.F.

PFE.F plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PFE.F stands at 121B. In comparison, PFE.DE has a market cap of 121.3B. Regarding current trading prices, PFE.F is priced at €20.72, while PFE.DE trades at €20.72.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PFE.F currently has a P/E ratio of 17.60, whereas PFE.DE's P/E ratio is 17.78. In terms of profitability, PFE.F's ROE is +0.09%, compared to PFE.DE's ROE of +0.09%. Regarding short-term risk, PFE.F and PFE.DE have similar daily volatility (0.68).

PFE.F plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PFE.F stands at 121B. In comparison, GIS.DE has a market cap of 117.3B. Regarding current trading prices, PFE.F is priced at €20.72, while GIS.DE trades at €94.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PFE.F currently has a P/E ratio of 17.60, whereas GIS.DE's P/E ratio is 22.79. In terms of profitability, PFE.F's ROE is +0.09%, compared to GIS.DE's ROE of +0.25%. Regarding short-term risk, PFE.F is less volatile compared to GIS.DE. This indicates potentially lower risk in terms of short-term price fluctuations for PFE.F.

PFE.F plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PFE.F stands at 121B. In comparison, SNW.DE has a market cap of 101.2B. Regarding current trading prices, PFE.F is priced at €20.72, while SNW.DE trades at €82.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PFE.F currently has a P/E ratio of 17.60, whereas SNW.DE's P/E ratio is 16.65. In terms of profitability, PFE.F's ROE is +0.09%, compared to SNW.DE's ROE of +0.08%. Regarding short-term risk, PFE.F is less volatile compared to SNW.DE. This indicates potentially lower risk in terms of short-term price fluctuations for PFE.F.

PFE.F plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PFE.F stands at 121B. In comparison, BRM.DE has a market cap of 82.9B. Regarding current trading prices, PFE.F is priced at €20.72, while BRM.DE trades at €39.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PFE.F currently has a P/E ratio of 17.60, whereas BRM.DE's P/E ratio is 17.49. In terms of profitability, PFE.F's ROE is +0.09%, compared to BRM.DE's ROE of +0.32%. Regarding short-term risk, PFE.F is less volatile compared to BRM.DE. This indicates potentially lower risk in terms of short-term price fluctuations for PFE.F.

PFE.F plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PFE.F stands at 121B. In comparison, BAYN.DE has a market cap of 26B. Regarding current trading prices, PFE.F is priced at €20.72, while BAYN.DE trades at €25.54.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PFE.F currently has a P/E ratio of 17.60, whereas BAYN.DE's P/E ratio is -7.97. In terms of profitability, PFE.F's ROE is +0.09%, compared to BAYN.DE's ROE of -0.10%. Regarding short-term risk, PFE.F is less volatile compared to BAYN.DE. This indicates potentially lower risk in terms of short-term price fluctuations for PFE.F.

PFE.F plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PFE.F stands at 121B. In comparison, BAYN.SG has a market cap of 25.9B. Regarding current trading prices, PFE.F is priced at €20.72, while BAYN.SG trades at €25.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PFE.F currently has a P/E ratio of 17.60, whereas BAYN.SG's P/E ratio is N/A. In terms of profitability, PFE.F's ROE is +0.09%, compared to BAYN.SG's ROE of -0.08%. Regarding short-term risk, PFE.F is more volatile compared to BAYN.SG. This indicates potentially higher risk in terms of short-term price fluctuations for PFE.F.

PFE.F plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PFE.F stands at 121B. In comparison, IDP.DE has a market cap of 15.5B. Regarding current trading prices, PFE.F is priced at €20.72, while IDP.DE trades at €107.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PFE.F currently has a P/E ratio of 17.60, whereas IDP.DE's P/E ratio is 12.18. In terms of profitability, PFE.F's ROE is +0.09%, compared to IDP.DE's ROE of +0.09%. Regarding short-term risk, PFE.F is less volatile compared to IDP.DE. This indicates potentially lower risk in terms of short-term price fluctuations for PFE.F.

PFE.F plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PFE.F stands at 121B. In comparison, GS7.DE has a market cap of 0. Regarding current trading prices, PFE.F is priced at €20.72, while GS7.DE trades at €20.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PFE.F currently has a P/E ratio of 17.60, whereas GS7.DE's P/E ratio is 17.31. In terms of profitability, PFE.F's ROE is +0.09%, compared to GS7.DE's ROE of +0.34%. Regarding short-term risk, PFE.F is less volatile compared to GS7.DE. This indicates potentially lower risk in terms of short-term price fluctuations for PFE.F.